Ittehad Chemicals shareholders approve annual resolutions, 30% final dividend and up to Rs. 1 billion additional investment in Biostacks
AGM / EGMAt its AGM held on October 28, 2026, Ittehad Chemicals shareholders approved the audited financial statements for the year ended June 30, 2026, a final cash dividend of Rs. 3 per share (30%) in addition to the interim dividend of Rs. 1 per share (10%) already paid, and the reappointment of BDO Ebrahim & Co. as auditor. Special resolutions also ratified related-party transactions and authorized an additional investment of up to Rs. 1 billion in associated company Biostacks (Pvt.) Limited, increasing the aggregate approved investment limit to Rs. 2 billion.
Payout
- 1st interim cash dividend Rs 1 per share (10%)
- Final cash dividend Rs 3 per share (30%)
Key Findings
- The AGM was held on October 28, 2026.
- Shareholders adopted the standalone and consolidated audited financial statements for the year ended June 30, 2026.
- A final cash dividend of Rs. 3 per share (30%) was approved; an interim dividend of Rs. 1 per share (10%) had already been paid.
- BDO Ebrahim & Co. was reappointed as auditor for the year ending June 30, 2027.
- Related-party transactions disclosed for FY ended June 30, 2026 were ratified, and the Board was authorized to approve such transactions during FY ending June 30, 2027 in the normal course of business.
Meeting Details
Meeting
Annual general meeting
Date
28/10/2026
Meeting Details
Agenda
- Receive, consider and approve the standalone and consolidated audited financial statements for the year ended June 30, 2026, with the Directors’ and Auditors’ reports and Chairman’s review report.
- Approve interim cash dividend already paid of Rs. 1 per share (10%) and final cash dividend of Rs. 3 per share (30%) for FY ended June 30, 2026.
- Appoint auditors for 2026-27 and fix their remuneration.
- Ratify and approve related-party transactions and authorize the Board to approve transactions with related parties during FY ending June 30, 2027.
- Approve additional investment of up to Rs. 1 billion in associated company Biostacks (Pvt.) Limited and enhance the aggregate approved investment limit to Rs. 2 billion.
Resolutions
- Ordinary Resolution #1: Adopt the standalone and consolidated annual audited financial statements for the year ended June 30, 2026, together with the related reports.
- Ordinary Resolution #2: Approve the interim cash dividend of Rs. 1 per share (10%) already declared and paid and the final cash dividend of Rs. 3 per share (30%).
- Ordinary Resolution #3: Reappoint BDO Ebrahim & Co. as auditors for the year ending June 30, 2027; authorize the CEO to negotiate remuneration.
- Special Resolution #4: Ratify related-party transactions disclosed in note #45 of the FY2026 financial statements and authorize future ordinary-course related-party transactions during FY2027.
- Special Resolution #5: Approve an additional investment of up to Rs. 1 billion in Biostacks (Pvt.) Limited, ratify the previously approved Rs. 1 billion investment, and enhance the aggregate investment limit to Rs. 2 billion. The resolution is valid for five years.
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.
